AT-1001(Astraea Therapeutics)

N/A

Report date: 2024/10/24 16:49:21
NME

Base Information

Drug NameAT-1001(Astraea Therapeutics)
Drug Alias NameAT-1001(Astraea Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha3beta4 nicotinic acetylcholine receptor agonists
TargetsAlpha3beta4 nicotinic acetylcholine receptor
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstraea Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesAstraea Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsTobacco Use Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A